- Nakamura, Muneaki;
- Srinivasan, Prashanth;
- Chavez, Michael;
- Carter, Matthew A;
- Dominguez, Antonia A;
- La Russa, Marie;
- Lau, Matthew B;
- Abbott, Timothy R;
- Xu, Xiaoshu;
- Zhao, Dehua;
- Gao, Yuchen;
- Kipniss, Nathan H;
- Smolke, Christina D;
- Bondy-Denomy, Joseph;
- Qi, Lei S
Repurposed CRISPR-Cas molecules provide a useful tool set for broad applications of genomic editing and regulation of gene expression in prokaryotes and eukaryotes. Recent discovery of phage-derived proteins, anti-CRISPRs, which serve to abrogate natural CRISPR anti-phage activity, potentially expands the ability to build synthetic CRISPR-mediated circuits. Here, we characterize a panel of anti-CRISPR molecules for expanded applications to counteract CRISPR-mediated gene activation and repression of reporter and endogenous genes in various cell types. We demonstrate that cells pre-engineered with anti-CRISPR molecules become resistant to gene editing, thus providing a means to generate "write-protected" cells that prevent future gene editing. We further show that anti-CRISPRs can be used to control CRISPR-based gene regulation circuits, including implementation of a pulse generator circuit in mammalian cells. Our work suggests that anti-CRISPR proteins should serve as widely applicable tools for synthetic systems regulating the behavior of eukaryotic cells.